Vepsitamab, CAS 2413453-53-7

Product Description: Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Joseph Chao, et al. Trial in progress: A phase I study of AMG 199, a half-life extended bispecific T-cell engager (HLE BiTE) immune therapy, targeting MUC17 in patients with gastric and gastroesophageal junction (G/GEJ) cancer. 2020 ASCO Annual Meeting I.

CAS Number: 2413453-53-7

Molecular Weight: N/A

Compound Purity: 98.44

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CD3

• SKU: MEXHY-P99523-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99523-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated